Primary Prevention of Thrombocytopenia Associated With T-DM1 Therapy in HER2 Positive Breast Cancer With Herombopag
Clinical trial NCT07198672 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07198672
- Sponsor
- Zhenzhen Liu
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-31
- Primary completion
- 2027-10-31
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.